Organization 【 display / non-display 】
-
2014.07.01 - 2020.03.31, Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Assistant Professor
-
2020.04.01 - , Advanced Pharmaco-science, Graduate School of Pharmaceutical Sciences, Associate Professor
Academic Papers 【 display / non-display 】
-
β2‐adrenergic stimulation induces interleukin‐6 by increasing Arid5a, a stabilizer of mRNA, through cAMP/PKA/CREB pathway in cardiac fibroblasts, Shota Tanaka, Atsuki Imaeda, Kotaro Matsumoto, Makiko Maeda, Masanori, Obana Yasushi Fujio, Pharmacology Research & Perspectives, 2020.04, Papers
-
Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodeling after myocardial infarction., Matsumoto, K., Obana, M., Kobayashi, A., Miyagawa, S., Maeda, M., Sakata, Y., Nakayama, H., Sawa, Y., Fujio, Y. , Cardiovasc. Res. ，115(4) 765-775, 2019.03, Papers
-
Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice., Imaeda A, Tanaka S, Tonegawa K, Fuchigami S, Obana M, Maeda M, Kihara M, Kiyonari H, Conway SJ, Fujio Y, Nakayama H., Biochemical and Biophysical Research Communications，510(1) 149-155, 2019.02, Papers
-
Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice, Atsuki Imaeda, Shota Tanaka, Kota Tonegawa, Shota Fuchigami, Masanori Obana, Makiko Maeda, Miho Kihara, Hiroshi Kiyonari, Simon J. Conway, Yasushi Fujio, Hiroyuki Nakayama, Biochemical and Biophysical Research Communications, 2019.01, Papers
-
Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer., Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, Kashiwagi Y, Sato A, Obana M, Yamamoto A, Kawasaki K, Lin Y, Kijima T, Kinehara Y, Miwa Y, Maeda S, Morii E, Kumanogoh A, Tsutsumi Y, Nagatomo I, Fujio Y., Oncotarget，9(101) 37520-37533, 2018.12, Papers